San Francisco, CA, May 9th, 2023 - VeriSIM Life (VeriSIM) www.verisimlife.com, the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, today announced a webinar hosted by CEO and Founder Dr. Jo Varshney, PhD and Dr. Jeff Barrett, PhD, Chief Science Officer at Aridhia Digital Research Environment (https://www.aridhia.com).
San Francisco, CA, May 9th, 2023 - VeriSIM Life (VeriSIM) www.verisimlife.com, the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, today announced a webinar hosted by CEO and Founder Dr. Jo Varshney, PhD and Dr. Jeff Barrett, PhD, Chief Science Officer at Aridhia Digital Research Environment (https://www.aridhia.com).
VeriSIM Life (VeriSIM) www.verisimlife.com, the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, today announced a partnership with Clarivate www.clarivate.com, a global leader in connecting people and organizations to intelligence they can trust.
VeriSIM Life (VeriSIM) www.verisimlife.com, the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, today announced a partnership with Clarivate www.clarivate.com, a global leader in connecting people and organizations to intelligence they can trust.
Frost & Sullivan recently assessed the artificial intelligence (AI)-enabled preclinical development industry, and, based on its analysis results, recognizes VeriSIM Life with the 2022 North America Competitive Strategy Leadership Award.
Frost & Sullivan recently assessed the artificial intelligence (AI)-enabled preclinical development industry, and, based on its analysis results, recognizes VeriSIM Life with the 2022 North America Competitive Strategy Leadership Award.
-p-800.jpeg)
.svg)
